# EDGAR Filing Document

**Accession Number:** 0001839435
**File Stem:** 0001839435-25-000008
**Filing Date:** 2025-8
**Character Count:** 31786
**Document Hash:** ca26d5ce5d0958886179c7eb94d7d00a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001839435-25-000008.hdr.sgml**: 20250825

**ACCESSION NUMBER**: 0001839435-25-000008

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250825

**EFFECTIVENESS DATE**: 20250825

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Octagon Capital Advisors LP
- **CENTRAL INDEX KEY:** 0001839435

**ORGANIZATION NAME:**
- **EIN:** 843576791
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-20958
- **FILM NUMBER:** 251248607

**BUSINESS ADDRESS:**
- **STREET 1:** 654 MADISON AVENUE
- **STREET 2:** 21ST FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10065
- **BUSINESS PHONE:** 212-369-2829

**MAIL ADDRESS:**
- **STREET 1:** 654 MADISON AVENUE
- **STREET 2:** 21ST FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10065

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001839435

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Octagon Capital Advisors LP

**Address:** 654 MADISON AVENUE, New York, NY 10065

**Telephone number:** 212-369-2829

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-20958

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** 549300LAL4WLS7BIZZ14

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                        | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                 | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| CSPC Pharmaceutical Group Limited     |  | 05/30/2025     | To authorise the board of directors to fix the remuneration of the directors                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |       21600000 |                0 | For         |                                 21600000 | FOR                         |  |
| 3SBio Inc.                            |  | 06/25/2025     | To authorise the board of directors of the company to fix the remuneration of the directors of the company                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |       12250000 |                0 | For         |                                 12250000 | FOR                         |  |
| Ascletis Pharma Inc.                  |  | 05/22/2025     | To authorise the board of directors to fix the remuneration of the directors                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        6500000 |                0 | For         |                                  6500000 | FOR                         |  |
| Duality Biotherapeutics, Inc.         |  | 06/20/2025     | To authorise the board of directors to fix the remuneration of the directors                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          38000 |                0 | For         |                                    38000 | FOR                         |  |
| Keymed Biosciences Inc.               |  | 06/26/2025     | To authorise the board of directors (the Board) to fix the remuneration of the directors                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         100000 |                0 | For         |                                   100000 | FOR                         |  |
| CStone Pharmaceuticals Co., Ltd.      |  | 06/25/2025     | To authorise the board of directors to fix the remuneration of the directors                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        7182000 |                0 | For         |                                  7182000 | FOR                         |  |
| Abivax SA                             | 00370M103 | 06/06/2025     | Approval of the compensation items paid during, or allocated for, the financial year 2024 to Mr. Marc de Garidel as Chair of the Board of Directors by interim and Chief Executive Officer                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1261594 |                0 | For         |                                  1261594 | FOR                         |  |
| Abivax SA                             | 00370M103 | 06/06/2025     | Approval of the compensation items paid during, or allocated for, the financial year 2024 to Ms. Sylvie Gr?goire as Chair of the Board of Directors                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        1261594 |                0 | For         |                                  1261594 | FOR                         |  |
| Abivax SA                             | 00370M103 | 06/06/2025     | Approval of the information on corporate officers' compensation included in the corporate governance report and referred to in Article L.22-10-9 I. of the French Commercial Code                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        1261594 |                0 | For         |                                  1261594 | FOR                         |  |
| Abivax SA                             | 00370M103 | 06/06/2025     | Approval of the compensation policy applicable to the Chair of the Board of Directors                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        1261594 |                0 | For         |                                  1261594 | FOR                         |  |
| Abivax SA                             | 00370M103 | 06/06/2025     | Approval of the compensation policy applicable to the Chief Executive Officer                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        1261594 |                0 | For         |                                  1261594 | FOR                         |  |
| Abivax SA                             | 00370M103 | 06/06/2025     | Approval of the compensation policy applicable to the Board members                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        1261594 |                0 | For         |                                  1261594 | FOR                         |  |
| Sensorion SA                          |  | 05/12/2025     | Setting of the amount of attendance fees to be allocated to the directors                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        7350000 |                0 | For         |                                  7350000 | FOR                         |  |
| Apellis Pharmaceuticals Inc.          | 03753U106 | 06/03/2025     | To hold an advisory vote to approve the compensation paid to our named executive officers                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |              1 |                0 | For         |                                        1 | FOR                         |  |
| Apellis Pharmaceuticals Inc.          | 03753U106 | 06/03/2025     | To hold an advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |              1 |                0 | 1 Year      |                                        1 | FOR                         |  |
| Atyr Pharma, Inc.                     | 002120202 | 05/01/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        3320000 |                0 | For         |                                  3320000 | FOR                         |  |
| Perspective Therapeutics, Inc.        | 46489V302 | 05/28/2025     | To consider and vote on a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive offi cers as disclosed in theProxy Statement.                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        1744829 |                0 | For         |                                  1744829 | FOR                         |  |
| Centessa Pharmaceuticals Plc          | 152309100 | 06/20/2025     | To receive and approve the Directors' Remuneration Policy as set out on pages A-3to A-25 of the Company's UK statutory directors' remuneration report for thefi nancial year ended December 31, 2024, which is set forth as Annex A to theattached proxy statement, which will take eff ect immediately after the end of theAGM. | SECTION 14A SAY-ON-PAY VOTES |        1030000 |                0 | For         |                                  1030000 | FOR                         |  |
| Cogent Biosciences, Inc.              | 19240Q201 | 06/04/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        2763000 |                0 | For         |                                  2763000 | FOR                         |  |
| Corbus Pharmaceuticals Holdings, Inc. | 21833P301 | 05/15/2025     | Approval, on an advisory basis, of the executive compensation of the Company's named executive officers                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |        1115000 |                0 | For         |                                  1115000 | FOR                         |  |
| DBV Technologies SA                   |  | 06/11/2025     | Approval of the information referred to in Article L.22-10-9 I of the French Commercial Code relating to the remuneration of corporate officers for the financial year 2024                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | For         |                                        3 | FOR                         |  |
| DBV Technologies SA                   |  | 06/11/2025     | Approval of the fixed, variable and exceptional elements making up the total remuneration and benefits of any kind, paid during the financial year 2024 or awarded for the same financial year to Mr. Michel de Rosen, Chairman of the board of directors                                                                        | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | For         |                                        3 | FOR                         |  |
| DBV Technologies SA                   |  | 06/11/2025     | Approval of the fixed, variable and exceptional elements making up the total remuneration and benefits of any kind, paid during the financial year 2024 or awarded for the same financial year to Mr. Daniel Tasse, Chief Executive Officer                                                                                      | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | For         |                                        3 | FOR                         |  |
| DBV Technologies SA                   |  | 06/11/2025     | Consultative opinion on the remuneration of executive managers' named executive officers' other than the Chief Executive Officer                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | For         |                                        3 | FOR                         |  |
| DBV Technologies SA                   |  | 06/11/2025     | Increase in the total remuneration (annual package) allocated to directors                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | For         |                                        3 | FOR                         |  |
| DBV Technologies SA                   |  | 06/11/2025     | Approval of the remuneration policy for the Chairman of the Board of directors for the financial year 2025                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | For         |                                        3 | FOR                         |  |
| DBV Technologies SA                   |  | 06/11/2025     | Approval of the remuneration policy for directors for the financial year 2025                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | For         |                                        3 | FOR                         |  |
| DBV Technologies SA                   |  | 06/11/2025     | Approval of the remuneration policy for the Chief Executive Officer and Deputy Chief Executive Officers for the financial year 2025                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | For         |                                        3 | FOR                         |  |
| DBV Technologies SA                   |  | 06/11/2025     | Authorisation to be granted to the board of directors to allocate free shares to employees and/or certain corporate officers                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | For         |                                        3 | FOR                         |  |
| DBV Technologies SA                   |  | 06/11/2025     | Authorisation to be granted to the board of directors to allocate options to subscribe for and/or purchase shares (stock options) to employees and/or certain corporate officers of the company orrelated companies or economic interest groupings                                                                               | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | For         |                                        3 | FOR                         |  |
| Dianthus Therapeutics, Inc.           | 252828108 | 05/22/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |        2341667 |                0 | For         |                                  2341667 | FOR                         |  |
| Gossamer Bio, Inc.                    | 38341P102 | 06/25/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |       17028613 |                0 | For         |                                 17028613 | FOR                         |  |
| MoonLake Immunotherapeutics AG        | 61559X104 | 06/05/2025     | Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         223000 |                0 | For         |                                   223000 | FOR                         |  |
| Merus N.V.                            |  | 05/21/2025     | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          15209 |                0 | For         |                                    15209 | FOR                         |  |
| Neurogene Inc.                        | 64135M105 | 06/12/2025     | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         201148 |                0 | For         |                                   201148 | FOR                         |  |
| Nuvation Bio Inc.                     | 67080N101 | 09/03/2024     | To approve, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        2984013 |                0 | For         |                                  2984013 | FOR                         |  |
| Nuvation Bio Inc.                     | 67080N101 | 05/21/2025     | To approve, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        2633504 |                0 | For         |                                  2633504 | FOR                         |  |
| Ocular Therapeutix, Inc.              | 67576A100 | 06/11/2025     | To approve an advisory vote on named excutive officer compensation                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |        2377588 |                0 | For         |                                  2377588 | FOR                         |  |
| Radiopharm Theranostics Limited       |  | 11/25/2024     | Approval to issue remuneration options to Director - Mr Paul Hopper                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |       93703148 |                0 | For         |                                 93703148 | NONE                        |  |
| Radiopharm Theranostics Limited       |  | 11/25/2024     | Approval to issue remuneration options to Director - Mr Riccardo Canevari                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |       93703148 |                0 | For         |                                 93703148 | NONE                        |  |
| Radiopharm Theranostics Limited       |  | 11/25/2024     | Approval to issue remuneration options to Director - Mr Lan Turner                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |       93703148 |                0 | For         |                                 93703148 | NONE                        |  |
| Radiopharm Theranostics Limited       |  | 11/25/2024     | Approval to issue remuneration options to Director - Mr Lan Turner                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |       93703148 |                0 | For         |                                 93703148 | NONE                        |  |
| Radiopharm Theranostics Limited       |  | 11/25/2024     | Approval to issue remuneration options to Director - Mr Noel Donnelly                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |       93703148 |                0 | For         |                                 93703148 | NONE                        |  |
| Radiopharm Theranostics Limited       |  | 11/25/2024     | Approval to issue remuneration options to Director - Mr Phillip Hains                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |       93703148 |                0 | For         |                                 93703148 | NONE                        |  |
| Radiopharm Theranostics Limited       |  | 11/25/2024     | Approval to issue remuneration options to Director - Mr Hester Larkin                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |       93703148 |                0 | For         |                                 93703148 | NONE                        |  |
| Radiopharm Theranostics Limited       |  | 11/25/2024     | Approval to issue remuneration options to Director - Dr Leila Alland                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |       93703148 |                0 | For         |                                 93703148 | NONE                        |  |
| Syndax Pharmaceuticals, Inc.          | 87164F105 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         751819 |                0 | For         |                                   751819 | FOR                         |  |
| Scholar Rock Holding Corporation      | 80706P103 | 05/22/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         329000 |                0 | For         |                                   329000 | FOR                         |  |
| Trevi Therapeutics Inc.               | 89532M101 | 06/11/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        2141587 |                0 | For         |                                  2141587 | FOR                         |  |
| Trevi Therapeutics Inc.               | 89532M101 | 06/11/2025     | Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to our named executive officers                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        2141587 |                0 | 1 Year      |                                  2141587 | FOR                         |  |
| Verona Pharma plc                     | 925050106 | 04/24/2025     | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         217264 |                0 | For         |                                   217264 | FOR                         |  |
| Verastem, Inc.                        | 92337C203 | 05/22/2025     | To approve an advisory vote on the compensation of the named excutive officers                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         701030 |                0 | For         |                                   701030 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Octagon Capital Advisors LP

**By (Signature):** Justin Hirsch

**By (Printed Signature):** Justin Hirsch

**By (Title):** Chief Compliance Officer, Chief Financial Officer

**Date:** 08/25/2025